# Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire

> **NCT07069439** · — · COMPLETED · sponsor: **Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization** · enrollment: 74 (actual)

## Conditions studied

- Drug Hypersensitivity
- Quality of Life (QOL)
- Caregivers
- Allergy and Immunology

## Interventions

- **BEHAVIORAL:** Turkish Version of the P-DrHy-Q

## Key facts

- **NCT ID:** NCT07069439
- **Lead sponsor:** Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-01
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07069439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07069439, "Turkish Version of the Parent-Reported Drug Hypersensitivity Quality of Life Questionnaire". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT07069439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*